Bruce D. Cheson, MD, FACP, FAAS, FASCO
Dr. Cheson attended the University of Virginia and then Tufts University Medical School. He completed his internship and residency in Internal Medicine at the University of Virginia Hospitals and then a clinical and research fellowship in Hematology at New England Medical Center Hospital. From 1977-1984 he was Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Utah. From 1986-2002, he was Head, Medicine Section, CTEP at the National Cancer Institute. Currently, Dr. Cheson is Professor of Medicine, Head of Hematology and Deputy Chief, Hematology-Oncology at Georgetown University Hospital, Lombardi Comprehensive Cancer Center.
Dr. Cheson has authored over 500 medical publications and abstracts and has contributed to over 60 texts. He is formerly Editor-in-Chief of Clinical Advances in Hematology, Associate Editor of the Journal of Clinical Oncology and Editor-in-Chief of Clinical Lymphoma, Leukemia and Myeloma. He is also on the editorial board of numerous journals. He has also been the editor of the American College of Physician’s Medical Knowledge Assessment Program in Oncology and the ASCO SEP. He has served on several committees of the American Society of Clinical Oncology and was on its Board of Directors, and edited ASCO News and ASCO Daily News. From 2002-2006, he was on the Oncologic Drug Advisory Committee to the U.S. Food and Drug Administration. He is past-Chair of the Lymphoma Committee of the Cancer and Leukemia Group B/Alliance, the Scientific Advisory Board of the Lymphoma Research Foundation, and the AJCC Subcommittee on Lymphoma. Dr. Cheson’s clinical interests focus on the development and evaluation of new therapeutic approaches for hematologic malignancies.